{"asctime": "2025-01-20 10:43:30", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}bookmarkEnd"}
{"asctime": "2025-01-20 10:43:30", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}bookmarkEnd"}
{"asctime": "2025-01-20 10:43:31", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}sdt"}
{"asctime": "2025-01-20 10:43:31", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}bookmarkEnd"}
{"asctime": "2025-01-20 10:43:31", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}bookmarkEnd"}
{"asctime": "2025-01-20 10:43:32", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}sectPr"}
{"asctime": "2025-01-20 10:43:45", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}bookmarkEnd"}
{"asctime": "2025-01-20 10:43:55", "name": "raw_docx", "levelname": "WARNING", "message": "Adding list item '[text='{Participants Who Become Pregnant During the Trial}', level='2']' to item but level jump greater than 1"}
{"asctime": "2025-01-20 10:43:56", "name": "raw_docx", "levelname": "WARNING", "message": "Adding list item '[text='{Participants Whose Partners Become Pregnant During the Trial}', level='2']' to item but level jump greater than 1"}
{"asctime": "2025-01-20 10:44:02", "name": "raw_docx", "levelname": "WARNING", "message": "Ignoring eTree element {http://schemas.openxmlformats.org/wordprocessingml/2006/main}sectPr"}


Results: Unmatched Items


| Template                                                                                     | Technical                                                                                                                                        |
|----------------------------------------------------------------------------------------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| Square brackets                                                                              | Country Identifier or Region Identifier or Site Identifier                                                                                       |
| Chevrons                                                                                     | Approval Date or State location where Information can be found                                                                                   |
| Original Protocol Indicator                                                                  | sponsor signature block name and title of sponsor signatory and signature date or This protocol was approved via describe method                 |
| Country Identifier                                                                           | Describe Method                                                                                                                                  |
| Region Identifier                                                                            | Amendment Details                                                                                                                                |
| Site Identifier                                                                              | The table below describes the current amendment                                                                                                  |
| State location where information can be found                                                | Approximately  enrolled GloballyLocallyby Cohort                                                                                                 |
| describe method                                                                              | Number or                                                                                                                                        |
| GloballyLocallyby Cohort                                                                     | Other description                                                                                                                                |
| Primary Reason for Amendment                                                                 | If yes briefly explain                                                                                                                           |
| Secondary Reason for Amendment                                                               | Table of Contents                                                                                                                                |
| Population type                                                                              | NonProprietary Names                                                                                                                             |
| Intervention model                                                                           | Intervention Model                                                                                                                               |
| Population diagnosis or condition                                                            | Population Type                                                                                                                                  |
| Control type                                                                                 | Control Type                                                                                                                                     |
| minimum age                                                                                  | Nonproprietary name or INN or Enter Not applicable                                                                                               |
| INN                                                                                          | or INN or                                                                                                                                        |
| Site distribution                                                                            | Minimum age                                                                                                                                      |
| Intervention assignment method                                                               | Intervention Assignment Method                                                                                                                   |
| Master Protocol Indicator                                                                    | Site Distribution                                                                                                                                |
| DrugDevice Combination Product Indicator                                                     | Blinded roles                                                                                                                                    |
| Adaptive Trial Design Indicator                                                              | randomly assigned to trial intervention enrolled                                                                                                 |
| blinded roles                                                                                | Table of Estimand Characteristics including Endpoint at a minimum                                                                                |
| randomly assigned to trial interventionenrolled                                              | PopulationLevel Summary                                                                                                                          |
| total planned duration of trial intervention                                                 | Secondary Objective X                                                                                                                            |
| total planned duration of trial intervention unit of time                                    | Secondary Objective Number                                                                                                                       |
| total planned duration of trial participation                                                | If a Secondary Objective has been entered Enter Table of Estimand Characteristics including Endpoint at a minimum                                |
| total planned duration of trial participation unit of time                                   | Intercurrent Event Strategy                                                                                                                      |
| Populationlevel Summary                                                                      | If an Exploratory Objective has been entered Enter Table of Estimand Characteristics including Endpoint at a minimum                             |
| Secondary Objective                                                                          | Intercurrent Event  Strategy                                                                                                                     |
| Rationale for Intervention Model                                                             | Rationale for Trial Intervention Model                                                                                                           |
| description of the overview of trial interventions or a heading for the optional table below | Prospective approval of protocol deviations to recruitment and enrollment criteria also known as protocol waivers or exemptions is not permitted |
| Select Arm Type                                                                              | To be eligible to participate in this trial an individual must meet all the following criteria                                                   |
| Select Intervention Type                                                                     | Inclusion Criterion                                                                                                                              |
| Select Pharmaceutical Dose Form                                                              | An individual who meets any of the following criteria will be excluded from participation in this trial                                          |
| Select Route of Administration                                                               | Exclusion Criterion                                                                                                                              |
| RegimenTreatment PeriodVaccination Regimen                                                   | Description of the overview of trial interventions or a heading for the optional table below                                                     |
| Select Use                                                                                   | Arm Type                                                                                                                                         |
| Select Sourcing                                                                              | Intervention Type                                                                                                                                |
| Background Trial Interventions                                                               | Pharmaceutical Dose Formulation                                                                                                                  |
| Other Noninvestigational Trial Intervention                                                  | RegimenTreatment PeriodVaccination regimen                                                                                                       |
| Clinical Laboratory Assessments                                                              | Use                                                                                                                                              |
| Definitions of Product Complaints                                                            | Sourcing                                                                                                                                         |
| Timing for reporting to Sponsor or Designee                                                  | Additional Text if Needed                                                                                                                        |
| Diseaserelated Events or Outcomes not Qualifying as AEs or SAEs                              | Background Trial Intervention                                                                                                                    |
| Statistical Analysis Method                                                                  | Other Noninvestigational Intervention                                                                                                            |
| Handling of Missing Data in Relation to Primary Estimands                                    | Clinical Safety Laboratory Assessments                                                                                                           |
| Analyses Associated with the Exploratory Objectives                                          | Definition of Product Complaints                                                                                                                 |
| CountryRegion Identifier                                                                     | Timing for Reporting to Sponsor or Designee                                                                                                      |
| CountryRegion Specific Requirements                                                          | Adverse Events of Special Interest or state Not applicable                                                                                       |
| CountryRegion Specific Protocol Clarifications                                               | Diseaserelated Events or Outcomes Not Qualifying as AEs or SAEs                                                                                  |
| enter amendment number                                                                       | Statistical Method of Analysis                                                                                                                   |
| enter date                                                                                   | Handling of Missing Data in Relation to Primary Estimand                                                                                         |
|                                                                                              | Analysis Associated with Exploratory Objectivess                                                                                                 |
|                                                                                              | CountryRegionSpecific Requirements                                                                                                               |
|                                                                                              | CountryRegionspecific Protocol Clarifications                                                                                                    |
|                                                                                              | Prior Protocol Amendments                                                                                                                        |
|                                                                                              | or                                                                                                                                               |
|                                                                                              | amendment number                                                                                                                                 |
|                                                                                              | Enter Appendix                                                                                                                                   |
